Latest Medical Devices News
TruScreen Maps NZ$4M Revenue Path in Global Expansion Update
Imricor Submits Third of Four FDA Modules Ahead of 2026 US Approval Target
EBR Systems Launches $150M Underwritten Raise for Wireless Pacing Expansion
CleanSpace Launches World’s First Loose-Fitting PAPR Certified for Europe
Micro-X Secures $1.6M ARPA-H Payment as Full Body CT Clears Design Review
Simble Solutions Eyes First Commercial Findings From Exclusive NanoSensor Platform
OncoSil Lands Rapid Oral Slot at ESMO GI 2026 After Hitting Study Endpoints
Medical Devices ETF Chart
Medical Devices Analysis
ResMed’s 51% Valuation Discount: Bargain or Fair Re-Rating?
Why ASX Healthcare Fell 16 Points Behind the Market in 5 Years
ResMed Shares Down 19.8%: Valuation Trap or Mispriced Opportunity?
Cochlear at AU$97: Quality Business or Permanent Impairment?
Cochlear Falls 63%: Generational Discount or Falling Knife?
Cochlear Stock: Reading the 70% P/S Compression After the Crash
ResMed Share Price at 52% Discount: Opportunity or Value Trap?
Cochlear at A$95: Bargain or Value Trap for ASX Investors?
Medical Devices Guides & Education
Discover More in the Medical Technology Hub
Go to Hub
How ASX Healthcare Investors Mispriced Risk Across Three Crashes
Echo IQ Teams With Mayo Clinic to Test AI Heart Risk Tool for Cancer Patients
Imricor Submits Third of Four FDA Modules Ahead of 2026 US Approval Target
EBR Systems Launches $150M Underwritten Raise for Wireless Pacing Expansion
Vitasora Raises $4M Nearly Triple Its Target as Billings Surge 70% in 2 Months
Imugene Posts 81% Response Rate and Lands Two FDA Fast Track Tags
ImpediMed Completes $2.1M Oversubscribed SPP Following $13.2M Placement
dorsaVi Locks in NTU Robotics IP to Complete Full Stack Safety Platform
Featured ASX Medical Devices Announcements
PainChek Locks in 4,000 UK Licences as Care Homes Prioritise Pain Tech
Video
Nova Eye Lifts FY26 Sales Guidance to US$22-23M After Record USA Sales in April
Video
AVITA Medical Clears RECELL GO for Launch in Australia and New Zealand Markets
Video
Latest ASX Medical Devices Videos
Medical Equipment Stocks: Industry Trends, Earnings and Investment Analysis
Medical equipment stocks span surgical systems, diagnostic imaging hardware, patient monitoring, and reusable procedural instruments, each with distinct revenue models and competitive barriers. The sector is characterised by long product lifecycles, regulatory moats, and deep hospital relationships that create durable earnings for established players. ASX-listed medical equipment companies have increasingly pursued international expansion to access larger addressable markets. StockWire X tracks earnings results, new product approvals, tender wins, and M&A activity across medical equipment stocks. Capital expenditure cycles in the hospital sector and healthcare funding decisions are key macro drivers our analysis monitors.
Frequently Asked Questions
What are the top 10 medical stocks on the ASX?
The ASX has a comprehensive medical sector spanning pharmaceuticals, medical devices, diagnostics, and health services. Top ASX medical stocks by market cap include globally significant businesses alongside a deep cohort of emerging companies. StockWire X covers ASX medical equipment stocks and the broader healthcare sector with analysis of earnings, clinical milestones, and market developments.
What are small medical device companies worth researching?
Small medical device companies on the ASX and globally offer investors exposure to innovative technology at earlier stages of development, where the return potential is highest. Key assessment criteria include regulatory pathway clarity, addressable market size, manufacturing scalability, and management track record. StockWire X covers small medical device and equipment companies with ongoing news and analysis.
What drives the share price of medical equipment stocks?
Medical equipment stock prices are driven by regulatory approvals and product launches, earnings results relative to guidance, contract and tender wins, acquisition activity, and the capital expenditure cycle in hospital systems. Companies with high recurring consumable and service revenue show more stable share price behaviour than those dependent on lumpy capital equipment sales.
How do hospital capital expenditure cycles affect medical equipment company revenues?
Medical equipment companies selling high-value capital equipment are significantly affected by hospital capital expenditure cycles. During periods of constrained hospital budgets, capital equipment purchases are often deferred, creating revenue headwinds. When hospital finances improve or government funding initiatives stimulate investment, equipment demand accelerates. Investors track hospital sector financial health and government infrastructure spending programmes to anticipate demand conditions.
What is the installed base business model and why is it valued highly in medical equipment investing?
The installed base model involves selling capital equipment competitively to establish a large customer base, then generating recurring, high-margin revenue from consumables, reagents, service contracts, and software. Companies with large installed bases generate predictable recurring revenues that are less cyclically sensitive than capital equipment sales alone. Investors value recurring revenue streams at higher multiples because they are more predictable and have lower customer acquisition costs.
Breaking ASX Alerts Direct to Your Inbox
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
- Breaking ASX announcements delivered within minutes
- Alerts delivered with expert analysis
- Optional text alert for subscribers
- No spam policy, unsubscribe any time